Related by context. All words. (Click for frequent words.) 74 eTag assays 72 microRNA biomarkers 72 biomarkers 72 genetic biomarkers 72 predictive biomarkers 72 biomarker assays 72 prognostic markers 72 molecular determinants 71 biomarker assay 71 novel peptide 70 kinase inhibition 70 diagnostic biomarkers 70 preclinically 70 pharmacodynamic biomarkers 70 splice variants 70 prognostic biomarkers 70 multiplex assay 70 molecular abnormalities 70 biomarker 70 diagnostic biomarker 70 anti angiogenic drugs 70 TLR9 agonists 70 Tr DNA 70 DNA methylation biomarkers 70 DNA methylation patterns 70 biologic pathways 70 A3 adenosine receptor 70 biomarker identification 70 small molecule agonists 70 miRNA biomarkers 70 validate biomarkers 69 genomic biomarkers 69 methylation markers 69 genomic proteomic 69 somatic mutations 69 small molecule activators 69 vitro assay 69 cell signaling pathways 69 proliferative disorders 69 PI3K AKT 69 molecular biomarker 69 small molecule modulators 69 cellular pathways 69 kidney urologic 69 throughput RNAi 69 antisense inhibitors 68 biomarker validation 68 siRNA therapeutics 68 potent inhibitors 68 diagnostic prognostic 68 protein biomarkers 68 tumor hypoxia 68 Anticalins R 68 K ras mutations 68 Symadex 68 intracellular signaling pathways 68 JAK inhibitors 68 metabolite profiling 68 multiplexed assays 68 antisense oligonucleotides 68 antiangiogenic agents 68 immunoregulation 68 therapeutic monoclonal antibody 68 protein biomarker 68 peptide antigens 68 biologic therapeutics 68 Anticalins ® 68 serum biomarkers 68 microRNA profiling 68 underlying molecular mechanisms 68 NF kB pathway 68 RNAi therapeutic targeting 68 NSCLC tumors 68 anticancer therapeutics 68 druggable targets 68 cMET 68 MEK inhibitors 68 OnDose TM 67 FGFs 67 tumorigenicity 67 myelofibrosis polycythemia vera 67 PIK3CA 67 gene fusions 67 metabonomics 67 epithelial tumors 67 tumor subtypes 67 delipidation 67 Trofex 67 Clusterin 67 small molecule inhibitors 67 proteomic analysis 67 LNP formulations 67 chemosensitivity 67 PARP inhibition 67 rxRNA 67 molecular profiling 67 PI3K inhibitors 67 protein microarrays 67 pharmacodynamic markers 67 TLR antagonists 67 GPCR targets 67 anti CD# antibodies 67 bioluminescent imaging 67 breast cancer metastasis 67 DNA methyltransferases 67 metabolomic profiles 67 LungExpress Dx TM 67 mechanistic insights 67 G Protein Coupled 67 investigational therapies 67 Fibroblast Growth Factor Receptor 67 theranostic 67 metabolomic 67 EGFR pathway 67 Squalamine 67 UsiRNAs 67 PCA3 gene 67 Protein Kinase C 66 atherosclerosis regression 66 ENMD # 66 P#X# 66 genetic polymorphisms 66 virulence genes 66 Galectin 3 66 Cardiotoxicity 66 metabolomic profiling 66 gene rearrangements 66 antagomirs 66 immunoregulatory 66 Epigenomics proprietary 66 miRview mets 66 CYT# potent vascular disrupting 66 EGFR HER2 66 Immunoassays 66 therapeutic regimens 66 differentially expressed proteins 66 p# biomarker 66 enzymatic pathways 66 pharmacogenetic testing 66 miRNA molecules 66 p# inhibitor 66 predictive toxicology 66 Locked Nucleic Acid LNA 66 pharmacogenetic test 66 Wnt signaling pathway 66 inhibit angiogenesis 66 therapeutic radiopharmaceuticals 66 Xanafide 66 DiLA2 66 vidofludimus 66 genomic biomarker 66 EGFR inhibition 66 Curaxin 66 microRNA expression 66 neuronal nicotinic receptors NNRs 66 immunotherapeutic approaches 66 validating biomarkers 66 IGF IR 66 DNA methylation markers 66 putative biomarkers 66 Theranostics 66 pathogenic mechanisms 66 MGd 66 selective inhibition 66 ESBA# 66 genomic alterations 66 gefitinib Iressa 66 protein electrophoresis 66 selectively inhibited 66 galectin 3 66 hERG 66 Li Fraumeni 66 PI3K/mTOR 66 immune modulating 66 histone deacetylase HDAC 66 genomic profiling 66 breast cancer subtypes 66 HepDirect prodrug 66 Hsp# inhibition 66 vascular disrupting agents 66 predictive biomarker 66 gene expression biomarkers 66 multitargeted 66 prognostic marker 66 sd rxRNA compounds 66 ADME Tox 66 prognostic indicators 66 HERmark assay 65 ALK inhibitors 65 non nucleoside 65 RNA antagonist 65 BioMAP 65 hypoxic tumors 65 #T# L1 65 siRNA therapeutic 65 genetic determinants 65 DNA methylation biomarker 65 gene expression assays 65 protein misfolding 65 molecularly targeted 65 Azedra 65 ADME properties 65 cellular immunotherapy 65 potent antiproliferative 65 kinase profiling 65 myeloproliferative disorders 65 epigenetic markers 65 antiangiogenic drugs 65 tubulin inhibitor 65 Genetic variations 65 engineered RAP peptides 65 KRAS mutation 65 HER2 overexpression 65 telomerase inhibitor 65 sirtuin therapeutics 65 CDK inhibitors 65 ProteinChip 65 non coding RNA 65 MAPK pathway 65 Smac mimetics 65 gene loci 65 ImmuKnow 65 splice junctions 65 anti angiogenic agents 65 THR beta agonist 65 GAP #B# 65 isoform selective 65 ALK mutations 65 chromosome aberrations 65 susceptibility loci 65 Onconase 65 HepDirect technology 65 TLR8 65 MAbs targeting 65 chemokine receptors 65 epigenetic therapies 65 causal variants 65 gastrointestinal stromal tumors GISTs 65 Spiegelmers R 65 anti CD3 65 apoptotic pathway 65 tissue fibrosis 65 metastatic neuroendocrine tumors 65 B7 H3 65 immunological diseases 65 rxRNA compounds 65 adenoviral 65 biomolecular interactions 65 proliferative diseases 65 protein tyrosine phosphatases 65 gene amplification 65 polycythemia vera PV 65 gene expression profiling 65 Mutation Analysis 65 vivo potency 65 KRAS oncogene 65 prognostic biomarker 65 mTOR inhibition 65 targeted anticancer therapies 65 Tß4 65 SELDI TOF MS 65 Rosetta Genomics microRNA 65 HCV protease inhibitors 65 genetic variants associated 65 Darapladib 65 pituitary adenomas 65 Src inhibitors 65 CBLC# 65 EGF receptors 65 multimodality imaging 65 CCR3 65 histone modifications 65 LRP5 65 immunotherapeutics 65 humanized monoclonal antibodies 65 Genetic variants 65 epigenetic therapeutics 65 OvaRex R 65 mda 7 65 AMPK activators 65 neuropsychiatric diseases 65 Cathepsin B 65 p# activation 65 molecular diagnostic assay 65 drug metabolizing enzymes 64 PDGF receptor 64 CCX# 64 KineMarker TM 64 AT1R 64 myeloproliferative diseases 64 signaling cascades 64 cerebrospinal fluid CSF 64 PCR primers 64 methylated DNA 64 miRNA expression 64 FTIs 64 murine models 64 ERK signaling 64 plasma kallikrein 64 mutational analysis 64 DOS# 64 diagnostic assays 64 JAK2 inhibitor 64 Pseudomonas aeruginosa infections 64 ChIP chip 64 Solazed TM 64 oncolytic viruses 64 cytolytic 64 etiologic 64 FGFR 64 histone deacetylase inhibitor 64 posttranslational modifications 64 proto oncogene 64 KL4 surfactant 64 annexin 64 Systemic Delivery 64 EGFR HER 64 CCR9 64 epigenetic mechanisms 64 optical biosensors 64 OMP #M# 64 Affibody ® molecules 64 mTOR inhibitors 64 HDAC inhibition 64 LungExpress Dx 64 adipogenic 64 JAK2 inhibitors 64 PDE# inhibitors 64 secretory pathway 64 Immunotherapeutic 64 serum antibodies 64 proton MR spectroscopy 64 florbetaben 64 Adnectin 64 SELDI 64 neurotrophic 64 proteoglycan 64 lymphoid tumors 64 oxysterols 64 NEUGENE R 64 antibody reagents 64 assay detects 64 NovaBay Aganocide compounds 64 causative mutations 64 N glycan 64 mGlu2 3 64 haematopoietic 64 HIF 1α 64 NuMimetic TM 64 quantitative proteomics 64 Nanobodies ® 64 monoclonal antibody therapies 64 molecular assays 64 ETBs 64 mesenchymal cell 64 carbohydrate polymers 64 HIF PH inhibitors 64 prostate carcinogenesis 64 kinase inhibitors 64 monoclonal antibody therapeutics 64 BioMAP ® Systems 64 immunomodulation 64 VKORC1 64 factor receptor FGFR 64 tumor microenvironment 64 intercellular signaling 64 therapeutic monoclonal antibodies 64 pharmacogenetic tests 64 phosphate S1P 64 miRview TM mets 64 PI3K Akt 64 NPM1 64 costimulatory 64 MMP inhibitors 64 peptide conjugated 64 multiplex assays 64 biologic pathway 64 neuropilin 64 NNR Therapeutics 64 oncogenesis 64 gene expression microarrays 64 RRM1 64 Epstein Barr Virus EBV 64 CTAP# Capsules 64 telomerase activators 64 vimentin 64 anticancer therapies 64 toxicogenomic 64 metalloprotease 64 antiproliferative effects 64 humanised antibody 64 Sphingomab 64 FGFR1 64 siRNA compounds 64 intracellular protein 64 miRNA profiling 64 resolvins 64 bisulfite sequencing 64 ANGPTL4 64 Factor Receptor 64 M2 subunit 64 immune modulatory 64 Lp PLA 2 64 chemopreventive agent 64 toxicogenomics 64 VeraTag assays 64 Fibroblast 64 antiangiogenic agent 64 biochemical markers 64 CellPort Technologies 64 NuroPro ® 64 miRview ™ mets 64 FISH fluorescence 64 ligand binding 64 TÎ ² 4 64 metabolite identification 64 bioinformatic approaches 64 novel VDA molecule 64 Cyclin E 64 immunological responses 64 Reports Preclinical Data 64 chromosomal rearrangement 64 multiplex PCR 64 CCR1 64 adult mesenchymal stem 64 biochemical assays 64 investigational humanized monoclonal antibody 64 PGxPredict tests 64 CXCR7 64 cationic lipid 64 mtDNA mutations 63 microtubule inhibitor 63 mGluR2 NAM 63 RT qPCR 63 CellSearch System 63 pre malignant lesions 63 ATTR CM 63 endoglin 63 SERMs 63 acadesine 63 silico prediction 63 synthetic peptides 63 PPARγ 63 endophenotypes 63 romazarit 63 cathepsins 63 MDRNA proprietary 63 Enzastaurin 63 biodistribution 63 GAGs 63 Anticalin ® 63 Fc gamma receptor 63 molecular imaging radiopharmaceuticals 63 p# biomarkers 63 Panzem 63 depsipeptide 63 SiMoA 63 radiotracers 63 identify protein biomarkers 63 intranasal delivery 63 Tesmilifene 63 quantitative gene expression 63 galectin 63 skeletal metastases 63 dasatinib Sprycel 63 HTS assay 63 pDCs 63 pleiotropic effects 63 gastric carcinomas 63 pancreatic lung 63 TOCOSOL Camptothecin 63 IGFBP2 63 VDAs 63 sDNA 63 Epidermal Growth Factor Receptor 63 HuLuc# 63 pharmacodynamic PD 63 small molecule activator 63 telomerase activation 63 siRNA nanoparticles 63 Vaxfectin TM 63 tumor antigens 63 preclinical efficacy 63 antiangiogenesis 63 Outpatient Setting 63 Alequel 63 flavopiridol 63 FLT3 63 HER2 expression 63 anti infective treatments 63 Dyax phage display 63 Mass spectrometry 63 5 hmC 63 missense mutations 63 novel peptides 63 microRNA miRNA 63 AttoSense 63 serine protease 63 xTAG RVP 63 optimal dosing regimens 63 VeraTag 63 vitamin D analogs 63 PKM2 63 chemoprevention trials 63 novel therapeutic antibodies 63 imatinib resistance 63 deacetylase inhibitors 63 enzyme cofactor 63 stratifying patients 63 genetic loci 63 FDG PET imaging 63 cellular signaling pathways 63 pharmacodynamic endpoints 63 cisplatin resistant 63 receptor subtypes 63 Nanobodies 63 pro angiogenic 63 anti fibrotic 63 tyrosine phosphorylation 63 molecular pathways 63 vivo validation 63 potently inhibit 63 immunotoxins 63 ChIP seq 63 JAK3 63 hypermethylated 63 favorable pharmacokinetic 63 adipose derived regenerative 63 pharmacogenomic tests 63 kallikrein 63 Septin9 63 immunochemical 63 cathepsin K 63 MyVax R 63 enzyme inhibitors 63 Angiolix 63 Marqibo TM 63 tests miRview TM 63 small molecule defensin 63 antitumor efficacy 63 vivo fluorescence imaging 63 pharmacodynamic parameters 63 molecular markers 63 causative genes 63 genetic aberrations 63 HepDirect R 63 Vidaza ® 63 biochemical profiling 63 PI3 kinase inhibitors 63 antimitotic 63 inactivating mutations 63 promoter methylation 63 noninvasive imaging 63 chemopreventive agents 63 aCGH 63 LSD1 63 PI3K inhibitor 63 TXNIP 63 protein kinases 63 pharmacologic approaches 63 sarcoma melanoma 63 BRAF inhibitors 63 vivo pharmacology 63 Hedgehog inhibitor 63 MAGE A3 ASCI 63 Fc gamma receptors 63 TLE3 63 rxRNA ™ compounds 63 compound AEZS 63 transgenic mouse models 63 therapeutics 63 epigenomic 63 indibulin 63 Factor VIIa 63 effector function 63 miRview ™ squamous 63 HCV replication 63 liposomal formulations 63 Corgentin 63 clinically validated 63 TTR gene 63 PET tracers 63 histone acetylation 63 oral prodrug 63 peptidic 63 monoclonal antibody mAb 63 pharmacogenetic 63 MEK ERK 63 mutational status 63 VEGF inhibitors 63 fosbretabulin 63 sortilin 63 neuroprotective properties 63 granzyme B 63 proteomic profiling 63 clusterin 63 Corus CAD 63 Nanobody 63 mitochondrial toxicity 63 Induced pluripotent stem cells 63 neuroinflammation 63 molecular diagnostic assays 63 hormone gastrin 63 Spiegelmers 63 Galectins 63 HSP# inhibitors 63 neuro protective 63 cardiometabolic disorders 63 immatics 63 inflammatory biomarkers 63 haplotyping 63 IGF 1R 63 therapeutically relevant 63 antiangiogenic activity 63 biomarker discovery 63 LHRH antagonists 63 serine proteases 63 Chemetics R 63 genomewide 63 methylation patterns 63 Personalized Immunotherapy 63 inhibiting enzymes 63 imatinib Gleevec 63 immunohistochemical 63 delafloxacin 63 Protein Expression 63 prostate cancer CaP 63 molecularly targeted therapies 63 Activating mutations 63 LNA TM 63 miR #a [001] 63 immuno modulatory 63 eIF 4E 63 Viprovex TM 63 Syllego system 63 p# inhibitors 63 isotypes 63 busulfan 63 motor neuron degeneration 62 trans splicing 62 antisense inhibitor 62 carbohydrate compounds 62 neurite outgrowth 62 KLF4 62 humanized monoclonal 62 iPS derived 62 hematopoietic malignancies 62 EGFR TKIs 62 molecular subtypes 62 polyketides 62 OGG1 62 novel immunotherapies 62 ADAMTS# 62 delta isoform 62 SOD1 gene 62 osteogenic 62 pathophysiological mechanisms 62 neovascular diseases 62 OnDose 62 SIRT1 activators 62 targeting CD# 62 fusion enhancers 62 neoplastic diseases 62 targeted radiotherapeutic 62 gene polymorphisms 62 glycan structures 62 ELISA assays 62 ALN TTR 62 p# INK4a 62 PGRN 62 tryptase 62 affinity ligands 62 Aviptadil 62 fast skeletal troponin 62 MAPCs 62 ALK inhibitor 62 hedgehog pathway 62 multiplex immunoassays 62 histone deacetylases 62 tumor histology 62 magnetic resonance spectroscopy MRS 62 orally administered inhibitor 62 epithelial cancers 62 biophysical techniques 62 Phylomer ® 62 antiplatelet therapies 62 CCR9 antagonist 62 vitro assays 62 mass spectrometric 62 Chemokine Receptor 62 physiologic mechanisms 62 modifier genes 62 qRT PCR 62 mimetic compounds 62 mRNA sequences 62 virulence determinants 62 serologic tests 62 miRview meso 62 Modrenal 62 Haptoglobin 62 therapeutic aptamers 62 uricase 62 Nanobody ® 62 GRP# 62 genes CYP#C# 62 ImmuKnow R 62 Zybrestat 62 thalidomide Thalomid 62 CINtec R 62 PITX2 62 sd rxRNA 62 Aurora kinase 62 mediated inhibition 62 constitutively expressed 62 gene locus 62 FGFR3 62 QuadraSphere 62 vinca alkaloid 62 radionuclide therapy 62 thymidylate synthase TS 62 tiapamil 62 Spiegelmers ® 62 fluoroquinolone resistance 62 experimentally validated 62 gp# protein [002] 62 small molecule tyrosine 62 Deforolimus 62 primate genomes 62 lentiviral vectors 62 prostate carcinomas 62 protein kinase C 62 Hedgehog signaling 62 VeraCode 62 Aurora Kinase 62 protein tyrosine phosphatase 1B 62 BRAF mutation 62 specific lectin receptors 62 epigenetic regulation 62 quantitative PCR qPCR 62 EGFr 62 histone deacetylase inhibitors 62 candidates Azedra TM 62 alpha fetoprotein AFP 62 splice variant 62 EpCAM 62 IL #p# 62 lymphatic mapping 62 fibrotic disease 62 STK# [002] 62 SSc 62 protein misfolding diseases 62 Mutational 62 Safinamide 62 quantitative trait loci 62 xenograft models 62 intracellular signal transduction 62 HDACs 62 chromosomal regions 62 rxRNA TM compounds 62 molecular pathogenesis 62 CA9 SCAN 62 Histone deacetylase 62 ONCONASE R 62 Stapled Peptide 62 Myeloperoxidase 62 carcinoembryonic antigen 62 drug GAP #B# 62 ncRNA 62 PPARg 62 bioluminescence imaging 62 antiangiogenic therapy 62 GSK3B 62 #ME# 62 Flow cytometry 62 cholesteryl ester transfer 62 siRNA duplexes 62 Luminex xMAP technology 62 mitotic kinesins 62 regenerative therapies 62 cells MSCs 62 RECAF TM 62 ischemic tissues 62 DNA demethylation 62 presymptomatic 62 theranostics 62 A2 Lp PLA2 62 Th2 cytokines 62 methylation profiling 62 Flt3 62 Bucindolol 62 TGFBR1 * 6A 62 Fas ligand 62 comparative genomic hybridization CGH 62 prostaglandin synthesis 62 Guanilib 62 XP #L 62 Bryostatin 62 Pentad TM 62 HepDirect 62 differentiate squamous 62 LHRH receptor positive 62 tumor specific antigen 62 trastuzumab Herceptin ® 62 HER1 62 AGHD 62 Immunohistochemistry 62 intracellular uptake 62 Glycosylation 62 HER3 62 #F FDG PET 62 CB2 receptor 62 sequence homology 62 tumor metastasis 62 electrophysiologic 62 Affymetrix microarray technology 62 ERK pathway 62 deCODE ProstateCancer TM 62 NuroPro R 62 HG PIN 62 adjuvant therapies 62 Sjögren syndrome 62 protein kinase inhibitors 62 Ceflatonin 62 VEGF receptor 62 idiopathic myelofibrosis 62 transcriptomic 62 TGF b 62 homodimers 62 mechanistic insight 62 p# MAPK 62 Chronix 62 TPMT 62 PROLARIS 62 exosome 62 JAK1 62 Rigel R# 62 NMR LipoProfile test 62 AEG# 62 orally bioavailable mimics 62 Hematopoietic 62 poly ethylene glycol PEG 62 miR #b [002] 62 transcriptomics proteomics 62 Listeria vaccine 62 multi analyte 62 T#I [002] 62 Eg5 62 lung pancreatic 62 Nanobacteria 62 EGFR mutation status 62 sirtuin activators 62 ubiquitin ligases 62 NS5A 62 Fludara ® 62 membrane receptors 62 gamete formation 62 Kinase Inhibitors 62 BACcel 62 immune modulation 62 immunomodulatory properties 62 Treg cell 62 drugable targets 62 #beta HSD 1 62 keratinocyte 62 extramedullary 62 antiviral compounds 62 DNA Methylation 62 KinomeScan 62 glycolipids 62 glycosylated 62 fatty acid biosynthesis 62 #S rRNA gene 62 Ampligen ® 62 ZNF# 62 estrogen receptor beta 62 HAAH 62 Tyrosine Kinase Inhibitor 62 transcriptional regulation 62 Neuradiab 62 matrix metalloproteases 62 co stimulatory molecules 62 endogenous ligands 62 chemo resistant 62 BrachySil TM 62 SELDI TOF 62 Exelixis compounds 62 ABL1 62 adeno associated viruses 62 ADVEXIN therapy 62 inhibit metastasis 62 multigene 62 hematopoietic cells 62 array CGH 62 commercialize deforolimus 62 comparative genomic hybridization 62 intracellular pathways 62 FGFR2 62 TTR amyloidosis 62 alpha#beta# integrin 62 molecular beacons 62 NKG2D 62 USP# 62 OTCBB PWRM.OB 62 synovial cells 62 Homspera TM 62 chromatin structure 62 Monoclonal antibody 62 percutaneous biopsy 62 GPx 62 chromatin immunoprecipitation ChIP 62 antibody arrays 62 pharmacological chaperone 62 biodistribution studies 62 Brussels THR 62 neratinib 62 cardiac repolarization 62 tumor antigen 62 prognostic significance 62 DCVax R 62 sPLA2 62 Biomerk Tumorgrafts 62 HDL Selective Delipidation 62 sphingolipids 62 RAV# 62 protein biochip 62 miRs 62 micro RNAs 62 xCELLigence System 62 Fleximer 62 gastric carcinoma 62 Leukemias 62 selective modulator 62 protein antigens 62 radiolabeled TM# 62 monoclonal antibody MAb 62 IAP inhibitors 62 glycopeptides 62 immuno inflammatory 62 benign neoplasms 62 HuCNS SC ® 62 PKC isoforms 62 hamartomas 62 quantitate 62 FOLOTYN ® 62 neovasculature 61 subcellular compartments 61 recombinant antibodies 61 E#F# 61 Pathway Inhibitor 61 immunohistochemical analysis 61 antiplatelet medications 61 ligand induced 61 phenotypic expression 61 bioactive molecules 61 epithelial tissues 61 Nektar proprietary 61 NTDDS 61 potency selectivity 61 Tyrima 61 gene methylation 61 RNA sequences 61 TLR9 agonist 61 EGFR tyrosine kinase inhibitors 61 HLA DQ2 61 EGFR inhibitors 61 ocular disorders 61 pathological hallmark 61 ArQule Kinase Inhibitor Platform 61 PI3K delta 61 HbF 61 c myb 61 metastatic colorectal 61 mAbs 61 Pertuzumab 61 HER2 HER3 61 proteomic biomarkers 61 mouse xenograft models 61 4E BP1 61 pediatric malignancies 61 MicroRNA 61 Aplidin 61 proteomic 61 oral JAK1 61 ChIP Seq 61 protein biosynthesis 61 radiotherapeutic 61 iPSC 61 mesothelin 61 varespladib 61 ALTROPANE 61 inhibit viral replication 61 endosomal release 61 lipid nanoparticles 61 differential gene expression 61 papillary renal cell carcinoma 61 hypoxia inducible factor 61 apoptosis inducing 61 histone deacetylase 61 tkRNAi